$0.45 EPS Expected for Quidel Corporation (QDEL) This Quarter
Equities research analysts expect Quidel Corporation (NASDAQ:QDEL) to post earnings of $0.45 per share for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for Quidel’s earnings, with estimates ranging from $0.24 to $0.62. Quidel reported earnings per share of ($0.06) in the same quarter last year, which would suggest a positive year-over-year growth rate of 850%. The firm is scheduled to issue its next earnings results on Wednesday, February 14th.
According to Zacks, analysts expect that Quidel will report full year earnings of $0.74 per share for the current financial year, with EPS estimates ranging from $0.15 to $1.06. For the next year, analysts expect that the business will report earnings of $1.99 per share, with EPS estimates ranging from $1.67 to $2.31. Zacks Investment Research’s EPS calculations are a mean average based on a survey of analysts that follow Quidel.
Quidel (NASDAQ:QDEL) last released its earnings results on Wednesday, November 1st. The company reported ($0.16) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.05 by ($0.21). The company had revenue of $50.89 million for the quarter, compared to analyst estimates of $50.47 million. Quidel had a negative net margin of 2.33% and a negative return on equity of 2.36%. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.10 EPS.
QDEL has been the topic of several research analyst reports. Raymond James Financial reissued a “buy” rating and set a $47.00 target price (up previously from $41.00) on shares of Quidel in a research note on Tuesday, September 19th. Zacks Investment Research cut shares of Quidel from a “buy” rating to a “hold” rating in a research note on Tuesday, November 7th. Barclays raised their price objective on shares of Quidel from $45.00 to $49.00 and gave the company an “overweight” rating in a research report on Thursday, November 2nd. Canaccord Genuity restated a “buy” rating and set a $48.00 price objective (up previously from $42.00) on shares of Quidel in a research report on Tuesday, September 19th. Finally, BidaskClub upgraded shares of Quidel from a “sell” rating to a “hold” rating in a research report on Saturday, December 2nd. Three analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Quidel currently has an average rating of “Buy” and an average target price of $48.80.
Quidel (QDEL) traded down $0.06 during trading on Monday, reaching $40.34. 216,055 shares of the company’s stock traded hands, compared to its average volume of 298,696. The company has a debt-to-equity ratio of 0.70, a quick ratio of 5.68 and a current ratio of 6.28. Quidel has a 52-week low of $18.25 and a 52-week high of $45.55.
In other Quidel news, SVP Ratan S. Borkar sold 7,965 shares of the firm’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $38.91, for a total value of $309,918.15. Following the completion of the transaction, the senior vice president now directly owns 11,084 shares in the company, valued at $431,278.44. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Werner Kroll sold 7,565 shares of the firm’s stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $39.50, for a total transaction of $298,817.50. Following the completion of the transaction, the senior vice president now owns 10,261 shares of the company’s stock, valued at $405,309.50. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 184,465 shares of company stock valued at $7,434,756. Insiders own 22.00% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the business. Acrospire Investment Management LLC boosted its holdings in shares of Quidel by 42.2% in the second quarter. Acrospire Investment Management LLC now owns 3,678 shares of the company’s stock worth $100,000 after buying an additional 1,091 shares during the period. Legal & General Group Plc boosted its holdings in shares of Quidel by 4.6% in the first quarter. Legal & General Group Plc now owns 6,931 shares of the company’s stock worth $157,000 after buying an additional 306 shares during the period. Great West Life Assurance Co. Can boosted its holdings in shares of Quidel by 162.7% in the third quarter. Great West Life Assurance Co. Can now owns 4,642 shares of the company’s stock worth $204,000 after buying an additional 2,875 shares during the period. Jane Street Group LLC acquired a new stake in shares of Quidel during the third quarter worth approximately $205,000. Finally, Russell Investments Group Ltd. acquired a new stake in shares of Quidel during the second quarter worth approximately $209,000. Institutional investors own 92.67% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This article was first published by Watch List News and is owned by of Watch List News. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.watchlistnews.com/0-45-eps-expected-for-quidel-corporation-qdel-this-quarter/1758215.html.
Quidel Company Profile
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Quidel Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.